Get started
Author

Ana Aurora Díaz-Gavela

Observed names: A. Diaz, A. Diaz Gavela, A. Diaz-Gavela, A. Díaz Gavela, A.A. Diaz Gavela, A.A. Diaz-Gavela, A.A. Díaz Gavela, A.A. Díaz-Gavela, Ana A Diaz-Gavela, Ana A. Diaz-Gavela, Ana A. Díaz-Gavela, Ana Aurora Diaz-Gavela, Ana Aurora DÍaz Gavela Luz, Ana Aurora Díaz Gavela, Ana Diaz-Gavela, Ana Díaz, Ana Díaz-Gavela, Aurora Díaz, Díaz-Gavela, Ana
Observed institutions: Oslo University Hospital, Hospital La Luz, Complejo Hospitalario Universitario de Santiago, Hospital Universitario Quirónsalud Madrid, Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario Puerta del Mar, IDCQ Hospitales y Sanidad, S.L.U., Medical University Pleven, Universidad Europea de Madrid
ORCID: 0000-0002-8453-5971
Observed ORCID: 0000-0002-8453-5971
OpenAlex ID: A5001263385
Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies
2021 · Ana Díaz-Gavela, Lourdes Figueiras-Graillet, et al. · Cancers · 69
PDF
Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
2019 · Felipe Couñago, Javier Luna, et al. · World Journal of Clinical Oncology · 59
PDF
Clinical Applications of Molecular Biomarkers in Prostate Cancer
2020 · Felipe Couñago, Fernando López-Campos, et al. · Cancers · 43
PDF
External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer
2014 · Ana Boladeras, Luigina Santorsa, et al. · Radiotherapy and Oncology · 23
Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy
2015 · Felipe Couñago, Elia del Cerro, et al. · SpringerPlus · 19
PDF
Role of 3.0 T multiparametric MRI in local staging in prostate cancer and clinical implications for radiation oncology
2014 · F. Couñago, M. Recio, et al. · Clinical & Translational Oncology · 19
Radiotherapy in Glioblastoma Multiforme: Evolution, Limitations, and Molecularly Guided Future
2025 · Castalia Fernández, Raquel Ciérvide, et al. · Biomedicines · 16
PDF
IJRadiation therapy for recurrent hydatid cyst of the pelvic bone: a case report
2021 · Marina Peña Huertas, Juan Zafra Martín, et al. · International Journal of Infectious Diseases · 9
Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience
2016 · Felipe Couñago, Manuel Recio, et al. · Cancer Imaging · 8
PDF
Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer
2019 · Felipe Couñago, Ana Aurora Díaz Gavela, et al. · Reports of Practical Oncology & Radiotherapy · 5
Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer
2025 · Victor Duque-Santana, Julio Fernandez, et al. · Cancers · 4
Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review
2023 · Elías Gomis Sellés, Daniela Gonsalves Pieretti, et al. · Future Oncology · 4
Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine
2021 · Ana Aurora Díaz-Gavela, Elia del Cerro Peñalver, et al. · Breast Disease · 4
Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain
2020 · Felipe Couñago, Claudio Martínez-Ballesteros, et al. · Reports of Practical Oncology & Radiotherapy · 4
PDF
Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer
2025 · Ana A. Díaz-Gavela, E. del Cerro, et al. · Radiation Oncology · 3
Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center
2024 · Ana Aurora Díaz-Gavela, Elia del Cerro Peñalver, et al. · Brachytherapy · 3
Magnetic resonance imaging (MRI) evaluation of pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).
2012 · Lucia Gonzalez-Cortijo, Javier Hornedo, et al. · Journal of Clinical Oncology · 3
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
2025 · Shelley Potter, Kerry Avery, et al. · npj Breast Cancer · 2
PDF
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
2023 · Victor Duque-Santana, Ana Diaz-Gavela, et al. · World Journal of Urology · 2
Breast radiotherapy in elderly women: myths, controversies, and current techniques in the adjuvant setting
2020 · Ana Aurora Díaz Gavela, Blanca Vaquero Barrón, et al. · Translational Cancer Research · 2
PDF
Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial
2025 · C. González San Segundo, F. López-Campos, et al. · Actas Urológicas Españolas (English Edition) · 1
Association between distinct intratumoral and stromal tumor infiltrating immune cells and pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).
2016 · Lucia Gonzalez-Cortijo, Raquel Murillo, et al. · Journal of Clinical Oncology · 1
929 Subclinical atherosclerosis: Risk marker for post-radiotherapy breast edema?
2026 · Ana A Diaz-Gavela, Elia del Cerro Peñalver, et al. · Radiotherapy and Oncology
Vascular calcifications in early-breast radiotherapy planning-CT: Opportunistic detection and cardiovascular risk assessment
2025 · Ana Aurora Diaz-Gavela, Julio Fernández-Mata, et al. · Clinical and Translational Radiation Oncology
PDF
Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer
2025 · Victor Duque-Santana, Julio Fernandez, et al. · Biomedicines
PDF
Works count: 72
Citation count: 303
H-index: 8
I10-index: 7
Year
Topic
Type